The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tereshchenko S.N.

National medical research center of cardiology MH RF

Perepech N.B.

Saint Petersburg State University, Saint Petersburg, Russia

Cheremisina I.A.

Alfasigma Rus LLC, Moscow, Russia

BYHEART observational trial of assessing exogenous phosphocreatine influence on the quality of life in patients with congestive heart failure

Authors:

Tereshchenko S.N., Perepech N.B., Cheremisina I.A.

More about the authors

Read: 1217 times


To cite this article:

Tereshchenko SN, Perepech NB, Cheremisina IA. BYHEART observational trial of assessing exogenous phosphocreatine influence on the quality of life in patients with congestive heart failure. Russian Journal of Cardiology and Cardiovascular Surgery. 2020;13(2):168‑170. (In Russ.)
https://doi.org/10.17116/kardio202013021168

References:

  1. Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D, Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Daniel Mullins C. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making. . 2017;20:1003-1008.
  2. Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Budi Siswanto B, Sliwa K, Filippatos G. Heart failure: preventing disease and death worldwide. . 2014 Sept;1(1):4-25. 
  3. Van Nuys KE, Xie Z, Tysinger B, Hlatky MA, Goldman DP. Innovation in Heart Failure Treatment. Life Expectancy, Disability, and Health Disparities. . 2018 May;6(5):410-412. 
  4. Taylor CJ, Ryan R, Nichols L, Gale N, Hobbs R, Marshall T. Survival following a diagnosis of heart failure in primary care. . 2017 April 1;34(2):161-168. 
  5. Heo S, Lennie TA, Okoli C, Moser DK. Quality of life in patients with heart failure: ask the patients. . 2009;38(2):100-108. 
  6. Moradi M, Daneshi F, Behzadmehr R, Rafiemanesh H, Bouya S, Raeisi M. Quality of life of chronic heart failure patients: a systematic review and meta-analysis. . Published: November 19, 2019.
  7. Nieminen MS, Dickstein K, Fonseca C, Serrano JM, Parissis J, Fedele F, Wikström G, Agostoni P, Atar S, Baholli L, Brito D, Colet JC, Édes I, Gómez Mesa JE, Gorjup V, Garza EH, González Juanatey JR, Karanovic N, Karavidas A, Katsytadze I, Kivikko M, Matskeplishvili S, Merkely B, Morandi F, Novoa A, Oliva F, Ostadal P, Pereira-Barretto A, Pollesello P, Rudiger A, Schwinger RH, Wieser M, Yavelov I, Zymliński R. The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations. . 2015 July 15;191:256-264. 
  8. Strumia E, Pelliccia F, D’Ambrosio G. Creatine phosphate: pharmacological and clinical perspectives. . 2012;29:99-123. PMID: 22297802.
  9. Horjus DL, Oudman I, van Montfrans GA, Brewster LM. Creatine and creatine analogues in hypertension and cardiovascular disease. . 2011;CD005184.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.